Table 2.
GO enrichment analysis of potential core targets for MHD against LC
| Term | Gene count | P-value |
|---|---|---|
| GO-BP:0045944~positive regulation of transcription from RNA polymerase II promoter | 61 | 1.73E-21 |
| GO-BP:0006351~transcription, DNA-templated | 55 | 5.17E-06 |
| GO-BP:0000122~negative regulation of transcription from RNA polymerase II promoter | 50 | 1.96E-19 |
| GO-BP:0043066~negative regulation of apoptotic process | 42 | 1.06E-20 |
| GO-BP:0016032~viral process | 40 | 1.38E-25 |
| GO-BP:0045892~negative regulation of transcription, DNA-templated | 39 | 8.99E-17 |
| GO-BP:0045893~positive regulation of transcription, DNA-templated | 38 | 1.84E-15 |
| GO-BP:0006355~regulation of transcription, DNA-templated | 37 | 0.00321423 |
| GO-BP:0098609~cell-cell adhesion | 33 | 8.60E-20 |
| GO-BP:0006915~apoptotic process | 31 | 1.90E-09 |